NO20013844L - Forgrenet kjede-aminosyreavhengige aminotransferase inhibitorer og deres anvendelse av diabetisk retinopati - Google Patents

Forgrenet kjede-aminosyreavhengige aminotransferase inhibitorer og deres anvendelse av diabetisk retinopati

Info

Publication number
NO20013844L
NO20013844L NO20013844A NO20013844A NO20013844L NO 20013844 L NO20013844 L NO 20013844L NO 20013844 A NO20013844 A NO 20013844A NO 20013844 A NO20013844 A NO 20013844A NO 20013844 L NO20013844 L NO 20013844L
Authority
NO
Norway
Prior art keywords
amino acid
branched chain
diabetic retinopathy
chain amino
acid dependent
Prior art date
Application number
NO20013844A
Other languages
English (en)
Norwegian (no)
Other versions
NO20013844D0 (no
Inventor
Justin Stephen Bryans
Lain-Yen Hu
Susan M Hutson
Kathryn Foley Lanoue
Erich Lieth
Michael Francis Rafferty
Todd Robert Ryder
Ti-Zhi Su
Devin Franklin Welty
David Juergen Wustrow
Original Assignee
Univ Wake Forest
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wake Forest filed Critical Univ Wake Forest
Publication of NO20013844D0 publication Critical patent/NO20013844D0/no
Publication of NO20013844L publication Critical patent/NO20013844L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/47—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/11—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20013844A 1999-12-08 2001-08-07 Forgrenet kjede-aminosyreavhengige aminotransferase inhibitorer og deres anvendelse av diabetisk retinopati NO20013844L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16963599P 1999-12-08 1999-12-08
US17539900P 2000-01-11 2000-01-11
US23002000P 2000-09-05 2000-09-05
PCT/US2000/030769 WO2001042191A1 (fr) 1999-12-08 2000-11-08 Inhibiteurs d'aminotransferase acides amines-dependante a chaine ramifiee, et leur utilisation dans le cadre du traitement de la retinopathie diabetique

Publications (2)

Publication Number Publication Date
NO20013844D0 NO20013844D0 (no) 2001-08-07
NO20013844L true NO20013844L (no) 2001-10-04

Family

ID=27389690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013844A NO20013844L (no) 1999-12-08 2001-08-07 Forgrenet kjede-aminosyreavhengige aminotransferase inhibitorer og deres anvendelse av diabetisk retinopati

Country Status (33)

Country Link
EP (1) EP1157000B1 (fr)
JP (1) JP2003516379A (fr)
KR (1) KR20010101811A (fr)
CN (2) CN1170811C (fr)
AP (1) AP2001002242A0 (fr)
AR (1) AR037738A1 (fr)
AT (1) ATE308510T1 (fr)
AU (1) AU784553B2 (fr)
BG (1) BG105875A (fr)
BR (1) BR0008443A (fr)
CA (1) CA2361647A1 (fr)
CO (1) CO5280055A1 (fr)
CZ (1) CZ20012758A3 (fr)
DE (1) DE60023657T2 (fr)
DZ (1) DZ3141A1 (fr)
EA (1) EA006597B1 (fr)
EE (1) EE200100416A (fr)
ES (1) ES2252075T3 (fr)
GE (1) GEP20043298B (fr)
HK (1) HK1044933B (fr)
HR (1) HRP20010581A2 (fr)
HU (1) HUP0200570A3 (fr)
IS (1) IS6033A (fr)
MA (1) MA26777A1 (fr)
MX (1) MXPA01008085A (fr)
NO (1) NO20013844L (fr)
OA (1) OA11759A (fr)
PE (1) PE20010929A1 (fr)
PL (1) PL349193A1 (fr)
SK (1) SK11022001A3 (fr)
UY (1) UY26474A1 (fr)
WO (1) WO2001042191A1 (fr)
YU (1) YU57401A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ES2296956T5 (es) * 2001-06-11 2011-07-12 Xenoport, Inc. Profármacos de análogos de gaba, composiciones y sus usos.
MXPA02010231A (es) * 2001-11-27 2004-12-13 Warner Lambert Co Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas.
MXPA02010430A (es) * 2001-11-27 2003-06-02 Warner Lambert Co Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas.
US20040058313A1 (en) * 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
EP1652845B1 (fr) * 2004-09-20 2007-11-14 Kao Corporation Procédé pour la préparation des lactones et leur utilisation comme substances odorantes
US8795725B2 (en) 2004-11-04 2014-08-05 Xenoport, Inc. GABA analog prodrug sustained release oral dosage forms
US8828665B2 (en) * 2007-02-16 2014-09-09 Ark Diagnostics, Inc. Compounds and methods for use in detecting gabapentin
WO2008155619A2 (fr) * 2007-06-21 2008-12-24 Pfizer Inc. Préparation d'acides aminés cycliques optiquement actifs
EP2383255A1 (fr) 2010-04-28 2011-11-02 Lacer, S.A. Nouveaux composés, synthèse et utilisation dans le traitement de la douleur
EP2481801A1 (fr) * 2011-01-28 2012-08-01 Deutsches Krebsforschungszentrum Inhibiteurs d'aminotransférase-1 (BCAT1) à chaîne branchée pour le traitement de la néoplasie
US9422224B2 (en) * 2011-06-13 2016-08-23 Ergon Pharmaceuticals Llc Methods of treatment using a BCAT1 inhibitor
US10941109B2 (en) 2011-06-13 2021-03-09 Ergon Pharmaceuticals Llc Compositions and methods of treatment using a BCAT1 inhibitor
CN113694202B (zh) * 2020-06-29 2023-03-31 江苏省中医院 Ass1或bckdk抑制剂在制备治疗溃疡性结肠炎的药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0888286T3 (da) * 1996-03-14 2002-02-18 Warner Lambert Co Nye substituerede cykliske aminosyrer som farmaceutiske midler

Also Published As

Publication number Publication date
IS6033A (is) 2001-07-31
HRP20010581A2 (en) 2002-08-31
GEP20043298B (en) 2004-03-10
AU784553B2 (en) 2006-05-04
MA26777A1 (fr) 2004-12-20
EP1157000A1 (fr) 2001-11-28
HK1044933A1 (en) 2002-11-08
BR0008443A (pt) 2001-10-30
PE20010929A1 (es) 2001-09-08
HK1044933B (zh) 2005-06-03
CN1626069A (zh) 2005-06-15
UY26474A1 (es) 2001-01-31
ATE308510T1 (de) 2005-11-15
BG105875A (en) 2002-05-31
AP2001002242A0 (en) 2001-09-30
DE60023657D1 (de) 2005-12-08
DE60023657T2 (de) 2006-07-20
CO5280055A1 (es) 2003-05-30
AR037738A1 (es) 2004-12-01
OA11759A (en) 2005-07-19
EP1157000B1 (fr) 2005-11-02
NO20013844D0 (no) 2001-08-07
DZ3141A1 (fr) 2001-01-14
CZ20012758A3 (cs) 2002-09-11
CA2361647A1 (fr) 2001-06-14
EA006597B1 (ru) 2006-02-24
HUP0200570A3 (en) 2003-02-28
HUP0200570A2 (en) 2002-06-29
EE200100416A (et) 2002-12-16
JP2003516379A (ja) 2003-05-13
KR20010101811A (ko) 2001-11-14
CN1170811C (zh) 2004-10-13
PL349193A1 (en) 2002-07-01
SK11022001A3 (sk) 2002-11-06
WO2001042191A1 (fr) 2001-06-14
MXPA01008085A (es) 2002-04-24
ES2252075T3 (es) 2006-05-16
EA200100791A1 (ru) 2002-04-25
AU1477901A (en) 2001-06-18
CN1344245A (zh) 2002-04-10
YU57401A (sh) 2004-05-12

Similar Documents

Publication Publication Date Title
NO20013844D0 (no) Forgrenet kjede-aminosyreavhengige aminotransferase inhibitorer og deres anvendelse av diabetisk retinopati
NO20020635D0 (no) Proteinpolymeriseringsinhibitorer og fremgangsmåter for anvendelse
NO20033099L (no) N-(fenylsulfonyl)glycin-derivater og deres terapeutiske anvendelse
NO20014409L (no) Dimere forbindelser og deres anvendelse som inhibitorer av neuraminidase
ATE314364T1 (de) Heterocyclische natrium/proton- austauschinhibitoren und verfahren
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
NO20014702D0 (no) Diarylderivater og deres anvendelse som medikamenter
DK1133477T3 (da) Substituerede benzimidazoler og deres anvendelse som parpinhibitorer
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
PT1245568E (pt) Derivados sulfonilo de aminoacidos e sua utilizacao enquanto inibidores da dipeptidil-peptidase iv (dpp iv)
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
IS6477A (is) Afleiður piperazíns og piperadíns
DK1399423T3 (da) Anthranilsyreamider med heteroarylsulfonyl-sidekæde og deres anvendelse som antiarrhytmiske aktive bestanddele
NO20032441D0 (no) Kombinasjon av GABA agonister og sorbitol-dehydrogenase inhibitorer
DK1164996T3 (da) Transdermalt terapeutisk system med nikotin og tilsat monoterpenketoner
EE200100371A (et) Amidinobensüülamiini derivaadid ja nende kasutamine trombiini inhibiitoritena
NO20022007L (no) Krystaller av et oksyiminoalkansyrederivat og deres anvendelse som antidiabetika
NO20020326L (no) Sammensetning og anvendelse av en inhibitor av PPAR-delta-aktivitet
NO20042137L (no) Antranilsyreamider og deres farmasoytiske anvendelse
DK1228026T3 (da) 15-Hydroxyicosatetraensyrerelaterede forbindelser og fremgangsmåde til anvendelse
NO20025884D0 (no) 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer
DK1187812T3 (da) Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer
DK1230227T3 (da) Benzoxa- og benzthiazolylsulfamater og anvendelse deraf som steroid-sulfataseinhibitorer
DK1244662T3 (da) Pyridazinoquinolinderivater og fremgangsmåde til behandling af smerter